Successful treatment of moderately ischaemic DFUs using intermittent topical oxygen
Summary: December 17, 2025 post hoc analysis from randomized double-blind sham-controlled study evaluates intermittent topical oxygen therapy (TWO2) for moderately ischaemic DFUs (UT grade 1-2, 1-20 cm², 4 weeks-1 year duration, failed ≥4 weeks standard care). Moderate ischemia per IWGDF: ABI ≥0.7, TBI <0.75, monophasic/biphasic Doppler, TcPO₂ <60 mmHg, toe pressure <60 mmHg, or skin perfusion pressure <60 mmHg. TWO2: cyclical pressurized oxygen (up to 10 L/min), non-contact compression (mobilizes fluids, reduces edema, improves inflow), humidification for diffusion. Patient-administered at home. Outcomes: 39% complete healing (100% epithelialization, confirmed over two visits) at 12 weeks vs. 0% sham (p<0.0076, ITT). Mechanisms: Forces oxygen into hypoxic tissue, elevates tension, lowers pH; upregulates NADPH oxidase (antimicrobial), ATP synthase (energy), prolyl/lysyl hydroxylase (collagen cross-linking), NOS (angiogenesis/flow). Reduces inflammation, bioburden; supports granulation/regeneration in ischemic DFUs. Relevant for chronic non-healing despite standard care (debridement, offloading, infection/moisture management); lowers recurrence (6x lower at 12 months in broader studies).
Key Highlights:
- Healing: 39% vs. 0% at 12 weeks; significant in moderate ischemia.
- Multimodal: Oxygen + compression + humidification synergy.
- Implications: Home-based adjunct; targets hypoxia barriers.
- Relevance: Expands options for ischemic/hard-to-heal DFUs.
Keywords: TWO2, intermittent topical oxygen, moderately ischaemic DFU, home-based therapy